Letter | Published:

Coffee contains potent opiate receptor binding activity

Naturevolume 301pages246248 (1983) | Download Citation



Opiate receptor-active peptide fragments (exorphins) have been identified recently in casein1 and gluten2 hydrolysates, and morphine has been found in bovine and human milk3. To determine whether similar peptides or alkaloids occur in other foodstuffs, we have screened potential sources using a rat brain homogenate assay to detect opiate receptor activity. We report here that instant coffee powders from a variety of manufacturers compete with tiitiated naloxone for binding to opiate receptors in the rat brain membrane preparations, with no significant difference between normal and decaffeinated coffee. The receptor binding activity resembles that seen with opiate antagonists, in that there was no change in the half-maximal effective dose (ED50) in the presence of 100 mM Na+; on bioassay, the activity was similarly shown to be antagonistic and specific for opiate-induced inhibition of twitch. Preliminary characterization of the activity reveals that it has a molecular weight (MW) in the range 1,000–3,500, is heat-stable, ether-extractable, not modified by enzymatic digestion with papain, and clearly separable from caffeine and morphine on TLC. As its concentration in an average cup of coffee is five times the ED50, these data suggest that drinking coffee may be followed by effects mediated via opiate receptors, as well as effects of caffeine.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Chang, K.-J., Killian, A., Hazum, E., Cuatrecasas, P., Chang, J.-K. Science 212, 75–77 (1981).

  2. 2

    Zioudrou, C., Streaty, R. A. & Klee, W. A., J. biol. Chem. 254, 2446–2449 (1979).

  3. 3

    Hazum, E., Sabatka, J. J., Chang, K.-J., Brent, D. A. & Findlay, J. W. A., Science 213, 1010–1012 (1981).

  4. 4

    Pert, C. B. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 70, 2243–2247 (1978).

  5. 5

    Pert, C. B., Pasternak, G., & Snyder, S. H. Science 182, 1359–1361 (1973).

  6. 6

    Arnold, M. A., Carr, D. B., Togasaki, D. M., Dian, M. C., & Martin, J. B. Life Sci. 31, 1017–1024 (1982).

  7. 7

    Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W., Proc. natn. Acad. Sci. U.S.A. 78, 3260–3264 (1981).

  8. 8

    Kosterlitz, H. W., Lydon, R. J. & Watt, A., Br. J. Pharmac. 39, 398–413 (1970).

Download references

Author information

Author notes

  1. M. J. Quinn: School of Pharmacology, Victorian College of Pharmacy, Parkville 3052, Australia

  2. K. N. Wynne: Ewen Downie Metabolic Unit, Alfred Hospital, Prahran 3181, Australia


  1. Medical Research Centre, Prince Henry's Hospital, Melbourne, 3004, Australia

    • J. H. Boublik
    • , M. J. Quinn
    • , J. A. Clements
    • , A. C. Herington
    • , K. N. Wynne
    •  & J. W. Funder


  1. Search for J. H. Boublik in:

  2. Search for M. J. Quinn in:

  3. Search for J. A. Clements in:

  4. Search for A. C. Herington in:

  5. Search for K. N. Wynne in:

  6. Search for J. W. Funder in:

About this article

Publication history



Issue Date



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.